An exciting new study from the team of Lucintel found that companion diagnostic market is expected to grow with a CAGR of 20%. There are significant money making opportunities available in this market and companies planning to enter this market need to differentiate in order to maximize their return on investment.
Download Brochure of this report by clicking on https://www.lucintel.com/companion-diagnostic-market.aspx
The companion diagnostic market is segmented based on indication, type, technology and region. In this market, oncology is expected to remain the largest indication. Players can benefit from the available opportunities like increasing technological advancements aimed at developing companion diagnostic tests for new indications such as neurology, infectious diseases, and so on.
F. Hoffmann-La Roche, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Biomérieux, Danaher, Illumina, Myriad Genetics, Arup Laboratories, Sysmex, Hologic, Novartis, Almac Group, and Abnova are some of the major players profiled in this 150 page report.
Request Sample Pages by clicking on
https://www.lucintel.com/companion-diagnostic-market.aspx
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the most promising potential, high-growth opportunities for the global companion diagnostic market by product and service (assays and reagents and software and services), technology (polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH) , next-generation sequencing, and other technologies), indication (oncology, neurology, others, and other indications), end use (pharmaceutical and biopharmaceutical companies, reference lab, and other end user), and region (North America, Europe, Asia-Pacific, and ROW)?Q.2 Which segments will grow at a faster pace and why?
Q.3 What are the business risks and threats to the companion diagnostic market?
Q.4 What are some changing demands of customers in the companion diagnostic market?
Q.5 What are the new developments in the companion diagnostic market? Which companies are leading these developments?
Q.6 What strategic initiatives are being implemented by key players for business growth?
Q.7 What are some of the competitive products and processes in this companion diagnostic area and how big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A activity has occurred in the last 5 years in this companion diagnostic market?
This unique report from Lucintel will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected]
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.